NFE2L2 and systemic sclerosis: Metformin downregulates NFE2L2 and could serve as a repurposed drug candidate.<h4>Conclusions</h4>SPP1 alveolar macrophages play a role in the profibrotic activity of IPF and SSc-ILD.